Literature DB >> 21161512

Nucleic acid aptamers for clinical diagnosis: cell detection and molecular imaging.

Boonchoy Soontornworajit1, Yong Wang.   

Abstract

Nucleic acid aptamers have recently attracted significant attention in the field of clinical diagnosis because they have numerous merits, such as high affinity, high specificity, small size, little immunogenicity, stable structures, and ease of synthesis. This review focuses on discussing the potential applications of aptamers in cell detection and molecular imaging. For the ex vivo cell detection, this review discusses the status of five strategies: endogenous nucleic acid analysis, flow cytometry analysis, nanoparticle-based cell sensing, microfluidic cell separation, and histological examination. This review also discusses in vivo molecular and cell imaging by introducing aptamer-based molecular imaging, cell imaging, and integrated imaging and therapy. On the basis of the status of these promising studies, this review summarizes several challenging issues and unmet needs that may require more effort or attention in the future.

Mesh:

Substances:

Year:  2010        PMID: 21161512     DOI: 10.1007/s00216-010-4559-x

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  21 in total

1.  Incorporation of isotopic, fluorescent, and heavy-atom-modified nucleotides into RNAs by position-selective labeling of RNA.

Authors:  Yu Liu; Erik Holmstrom; Ping Yu; Kemin Tan; Xiaobing Zuo; David J Nesbitt; Rui Sousa; Jason R Stagno; Yun-Xing Wang
Journal:  Nat Protoc       Date:  2018-04-12       Impact factor: 13.491

2.  In vitro selection of modified RNA aptamers against CD44 cancer stem cell marker.

Authors:  Nidaa Ababneh; Walhan Alshaer; Omar Allozi; Azmi Mahafzah; Mohammed El-Khateeb; Hervé Hillaireau; Magali Noiray; Elias Fattal; Said Ismail
Journal:  Nucleic Acid Ther       Date:  2013-10-30       Impact factor: 5.486

3.  Pharmacokinetic characterization of an RNA aptamer against osteopontin and demonstration of in vivo efficacy in reversing growth of human breast cancer cells.

Authors:  Lindsay Jones Talbot; Zhiyong Mi; Syamal Dave Bhattacharya; Victoria Kim; Hongtao Guo; Paul C Kuo
Journal:  Surgery       Date:  2011-08       Impact factor: 3.982

Review 4.  The role of nuclear medicine in modern therapy of cancer.

Authors:  Gabriela Kramer-Marek; Jacek Capala
Journal:  Tumour Biol       Date:  2012-03-24

5.  RNA aptamers and their therapeutic and diagnostic applications.

Authors:  Katherine Germer; Marissa Leonard; Xiaoting Zhang
Journal:  Int J Biochem Mol Biol       Date:  2013-03-31

6.  Aptamers: problems, solutions and prospects.

Authors:  A V Lakhin; V Z Tarantul; L V Gening
Journal:  Acta Naturae       Date:  2013-10       Impact factor: 1.845

7.  In vitro selection of RNA aptamer and specific targeting of ErbB2 in breast cancer cells.

Authors:  Mee Young Kim; Sunjoo Jeong
Journal:  Nucleic Acid Ther       Date:  2011-06       Impact factor: 5.486

8.  Selection of a novel DNA thioaptamer against HER2 structure.

Authors:  Y Hu; J Duan; B Cao; L Zhang; X Lu; F Wang; F Yao; Z Zhu; W Yuan; C Wang; X-D Yang
Journal:  Clin Transl Oncol       Date:  2015-05-29       Impact factor: 3.405

9.  Development of RNA aptamers targeting Ebola virus VP35.

Authors:  Jennifer M Binning; Tianjiao Wang; Priya Luthra; Reed S Shabman; Dominika M Borek; Gai Liu; Wei Xu; Daisy W Leung; Christopher F Basler; Gaya K Amarasinghe
Journal:  Biochemistry       Date:  2013-11-14       Impact factor: 3.162

10.  Inhibition of pre-mRNA splicing by a synthetic Blom7α-interacting small RNA.

Authors:  Marlies Löscher; Markus Schosserer; Eric Dausse; Kiseok Lee; Paul Ajuh; Regina Grillari-Voglauer; Angus I Lamond; Jean-Jacques Toulmé; Johannes Grillari
Journal:  PLoS One       Date:  2012-10-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.